Amble Health
Amble Health is a 2023-founded compounded-GLP-1 telehealth brand offering flat, dose-independent monthly pricing for semaglutide and tirzepatide, bundled with consults and shipping.
What we like
What to watch
Full Review
Amble Health launched in 2023 and reports serving all 50 states, prescribing compounded semaglutide and tirzepatide at a flat monthly rate that doesn't change with dose — $179 for a single month, dropping to $135/month on a 6-12 month commitment, with consults, supplies, and shipping included. The company states it has treated over 100,000 members and carries a strong Trustpilot profile (4.5/5 across roughly 4,500 reviews), with most complaints centered on shipping temperature control and slow support during billing or cancellation disputes. Amble does not publicly name its compounding pharmacy partner, a transparency gap relative to competitors that disclose 503A/503B sourcing. As one of the newer entrants in the category, it has a shorter track record than established compounded-GLP-1 players.
Last researched: 2026-09-19
Pricing
Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.
| Treatment | Category | Price/mo | Includes | Notes |
|---|---|---|---|---|
| Compounded Semaglutide | Weight Loss / GLP-1 | $135–$179 | ● Consults○ Lab work● Shipping | Subscription required |
| Compounded Tirzepatide | Weight Loss / GLP-1 | $135–$179 | ● Consults○ Lab work● Shipping | Subscription required |